Evidence map›Paper›PMID 38965085›Full record

ArticlePsychopharmacology2024

Reinforcing effects of fentanyl analogs found in illicit drug markets.

Alexander D Maitland, Shelby A McGriff, Grant C Glatfelter, Charles W Schindler, Michael H Baumann

Abstract read
In one paragraph

Article in Psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander D MaitlandDesigner Drug Research Unit (DDRU), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA.
Shelby A McGriffDesigner Drug Research Unit (DDRU), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA.
Grant C GlatfelterDesigner Drug Research Unit (DDRU), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA.
Charles W SchindlerDesigner Drug Research Unit (DDRU), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA.
Michael H BaumannDesigner Drug Research Unit (DDRU), National Institute on Drug Abuse (NIDA), Intramural Research Program (IRP), 333 Cassell Drive, Suite 4400, Baltimore, MD, 21224, USA. mbaumann@mail.nih.gov.ORCID http://orcid.org/0000-0001-7758-1470

Funding

Studies on MDMA and Related CompoundsZIADA000523 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$16.4M
6 · The paper itself

Abstract

rationaleThe potent synthetic opioid fentanyl, and its analogs, continue to drive opioid-related overdoses. Although the pharmacology of fentanyl is well characterized, there is little information about the reinforcing effects of clandestine fentanyl analogs (FAs).

objectivesHere, we compared the effects of fentanyl and the FAs acetylfentanyl, butyrylfentanyl, and cyclopropylfentanyl on drug self-administration in male and female rats. These FAs feature chemical modifications at the carbonyl moiety of the fentanyl scaffold.

methodsSprague-Dawley rats fitted with intravenous jugular catheters were placed in chambers containing two nose poke holes. Active nose poke responses resulted in drug delivery (0.2 mL) over 2 s on a fixed-ratio 1 schedule, followed by a 20 s timeout. Acquisition doses were 0.01 mg/kg/inj for fentanyl and cyclopropylfentanyl, and 0.03 mg/kg/inj for acetylfentanyl and butyrylfentanyl. After 10 days of acquisition, dose-effect testing was carried out, followed by 10 days of saline extinction.

resultsSelf-administration of fentanyl and FAs was acquired by both male and female rats, with no sex differences in acquisition rate. Fentanyl and FAs showed partial inverted-U dose-effect functions; cyclopropylfentanyl and fentanyl had similar potency, while acetylfentanyl and butyrylfentanyl were less potent. Maximal response rates were similar across drugs, with fentanyl and cyclopropylfentanyl showing maximum responding at 0.001 mg/kg/inj, acetylfentanyl at 0.01 mg/kg/inj, and butyrylfentanyl at 0.003 mg/kg/inj. No sex differences were detected for drug potency, efficacy, or rates of extinction.

conclusionsOur work provides new evidence that FAs display significant abuse liability in male and female rats, which suggests the potential for compulsive use in humans.

Indexed as

Analgesics, OpioidFentanylIllicit DrugsRats, Sprague-DawleyReinforcement, PsychologySelf AdministrationAnimalsDose-Response Relationship, DrugFemaleMaleRatsAnalgesics, OpioidFentanylIllicit DrugsFentanylFentanyl analogMu-opioid receptorOpioidReinforcementSelf-administration

Identifiers

PMID38965085
PMCPMC11513704

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.